Blue Diamond® Retail Roll-out

RNS Number : 7036M
Futura Medical PLC
11 May 2015
 

For immediate release

11 May 2015

 

 

Futura Medical plc

("Futura" or "the Company")

 

Blue Diamond® Retail Roll-out

 

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that Blue Diamond®, the Company's own brand of its novel CSD500 condom, is shortly to be distributed to more than 600 drug stores throughout the Netherlands, opening up a high street channel to complement the product's online sales.

 

Blue Diamond® was launched online in the Netherlands in October last year by Futura's distribution partner in the region. The product's availability in-store is an encouraging step as approximately 75% of condom sales are transacted through the drug store channel in the Netherlands.

 

The 600 drug stores in which Blue Diamond® will be stocked are owned by two of the largest drug store chains in the Netherlands. The in-store launch of Blue Diamond® will be accompanied by an advertising campaign including targeted radio advertising and in-store promotion.

 

James Barder, Futura's Chief Executive, commented: "Following the online launch of the Blue Diamond® brand in the Netherlands last year, it is encouraging that the product will now also be available in more than 600 drug stores in the country. We look forward to monitoring the sales progress of Blue Diamond® during the months ahead."

 

 

 

For further information please contact:

 

Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

 

N+1 Singer (Nominated Adviser and Broker)


Aubrey Powell / Tom Smale - Corporate Finance

 

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:


Buchanan


Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGKVRGGKZM
UK 100

Latest directors dealings